In vitro study on the anticancer effects of oxalipalladium against PC3 human prostate carcinoma cells.

MLA

Fathi, Zahra, et al. “In Vitro Study on the Anticancer Effects of Oxalipalladium against PC3 Human Prostate Carcinoma Cells.” Toxicology and Applied Pharmacology, vol. 490, Sept. 2024, p. 117021. EBSCOhost, https://doi.org/10.1016/j.taap.2024.117021.

APA

Fathi, Z., Avanes, A., & Jahanafrooz, Z. (2024). In vitro study on the anticancer effects of oxalipalladium against PC3 human prostate carcinoma cells. Toxicology and Applied Pharmacology, 490, 117021. https://doi.org/10.1016/j.taap.2024.117021

Chicago

Fathi, Zahra, Armen Avanes, and Zohreh Jahanafrooz. 2024. “In Vitro Study on the Anticancer Effects of Oxalipalladium against PC3 Human Prostate Carcinoma Cells.” Toxicology and Applied Pharmacology 490 (September): 117021. doi:10.1016/j.taap.2024.117021.